2,N,N-TMT

2,N,N-TMT
	File:2,N,N-TMT.svg
Identifiers
	IUPAC name (2-(2-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C13H18N2
Molar mass	202.30 g/mol

2,N,N-trimethyltryptamine (2,N,N-TMT, 2-Me-DMT, 2-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#34) ^[1]. It is claimed to show psychoactive effects at a dosage of 50-100mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT_2A receptor target that mediates the hallucinogenic effects of these drugs.

Template:Hallucinogen-stub

References

↑ http://www.erowid.org/library/books_online/tihkal/tihkal34.shtml

Template:TiHKAL Template:Hallucinogenic tryptamines

Template:WikiDoc Sources

[1] ttp://www.erowid.org/library/books_online/tihkal/tihkal34.shtml

[1]

Identifiers
File:2,N,N-TMT.svg
IUPAC name (2-(2-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₃H₁₈N₂
Molar mass	202.30 g/mol

2,N,N-TMT

References

Navigation menu